The Daily

California is poised to become the first state to outlaw discrimination based on a person’s caste. The system of social stratification, which dates back thousands of years, has been outlawed in India and Nepal for decades.Amy Qin, a correspondent who covers Asian American communities for The Times, explains why so many believe a prejudice that originated on the other side of the globe now requires legal protection in the U.S.  — and why so many are equally convinced that it would be a bad idea.Guest: Amy Qin, a national correspondent covering Asian American communities for The New York Times.Background reading: The bill, recently passed by the California State Legislature, has led to intense debate among South Asian immigrants.Meena Kotwal, a Dalit journalist, started a news outlet focused on marginalized groups in India, hoping that telling their stories would help improve their lives.For more information on today’s episode, visit nytimes.com/thedaily Transcripts of each episode will be made available by the next workday.

“The weird thing about growing up kidnapped,” Shane McCrae, the 47-year-old American poet, told me in his melodious, reedy voice one rainy afternoon in May, “is if it happens early enough, there’s a way in which you kind of don’t know.”There was no reason for McCrae to have known. What unfolded in McCrae’s childhood — between a day in June 1979 when his white grandmother took him from his Black father and disappeared, and another day, 13 years later, when McCrae opened a phone book in Salem, Ore., found a name he hoped was his father’s and placed a call — is both an unambiguous story of abduction and a convoluted story of complicity. It loops through the American landscape, from Oregon to Texas to California to Oregon again, and, even now, wends through the vaster emotional country of a child and his parents. And because so much of what happened to McCrae happened in homes where he was beaten and lied to and threatened, where he was made to understand that Black people were inferior to whites, where he was taught to hail Hitler, where he was told that his dark skin meant he tanned easily but, no, not that he was Black, it’s a story that’s been hard for McCrae to piece together.McCrae’s new book, the memoir “Pulling the Chariot of the Sun,” is his attempt to construct, at a remove of four decades, an understanding of what happened and what it has come to mean. The memoir takes the reader through McCrae’s childhood, from his earliest memories after being taken from his father to when, at 16, he found him again.his story was recorded by Audm. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.

Warning: This episode contains descriptions of rape, sexual abuse and death.As an epidemic of fentanyl use continues in America, causing tens of thousands of deaths each year, lawmakers and law enforcement agencies are holding one group increasingly responsible: drug users themselves.Eli Saslow, a writer for The Times, tells the story of a man whose friendship ended in tragedy and a set of laws that say he is the one to blame.Guest: Eli Saslow, a writer at large for The New York Times.Background reading: Two friends bought $30 worth of fentanyl before making it into rehab. One overdosed. The other was charged in his death.Harsh fentanyl laws ignite a fierce debate. Critics say, the approach could undermine public health goals and advances in addiction treatment.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Warning: This episode contains descriptions of violence.The relationship between two democratic allies fell to its lowest point in history this week, after Canada accused India of assassinating a Sikh community leader in British Columbia in June.Mujib Mashal, The Times’s South Asia bureau chief, explains this stunning accusation — and what India’s reaction to it tells us about the era of its leader, Narendra Modi.Guest: Mujib Mashal, The New York Times’s bureau chief for South Asia.Background reading: Prime Minister Justin Trudeau of Canada said agents of India had assassinated a Sikh community leader, Hardeep Singh Nijjar, who was fatally shot in British Columbia in June.Mr. Nijar was a prominent advocate of the creation of an independent Sikh nation that would include parts of India’s Punjab State.The charge, which the Indian government has strongly rejected, may fuel a rift between Canada’s Sikhs and Hindus.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

New research and polling show that more and more Americans now doubt a previously unquestioned fact of U.S. life — that going to college is worth it.Paul Tough, a contributing writer for The New York Times Magazine, explains why so many high-school students and their parents are souring on higher education and what it will mean for the country’s future.Guest: Paul Tough, a contributing writer for The New York Times Magazine who has written several books on inequality in education.Background reading: Americans are losing faith in the value of college. Whose fault is that?In December, Colby-Sawyer in New Hampshire reduced its tuition to $17,500 a year, from about $46,000. The cut was a recognition that few pay the list price.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

As Ukraine’s counteroffensive grinds on, it’s increasingly turning to a secret drone program that is hitting targets deep inside Russian territory. At least three different Ukrainian-made drones have been used in attacks inside Russia, including on Moscow, according to an analysis by The New York Times.Christiaan Triebert, a journalist on The Times’s Visual Investigations team, explains the origins of that program. We also speak to Serhiy Prytula, a former Ukrainian television host who is now a key force behind it.Guest: Christiaan Triebert, a journalist on The New York Times’s Visual Investigations team.Background reading: Officials in Ukraine rarely discuss attacks on targets inside Russia, including Moscow. But video evidence shows an increasing effort to launch long-range strikes inside the country.Moscow said Ukraine used drones to strike Novorossiysk, a Black Sea naval and shipping hub, and a port in occupied Crimea.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.Dani Blum, a reporter for The Times, tells the story behind the drugs and describes some of the ramifications of using them.Guest: Dani Blum, a reporter for Well at The New York Times.Background reading: Ozempic can cause major weight loss. What happens if you stop taking it?Some people taking the drugs can experience such intense lack of appetite that they become malnourished.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Twenty years ago, a glamorous platinum-blond widow arrived at the Paris law office of Claude Dumont Beghi in tears. Someone was trying to take her horses — her “babies” — away, and she needed a lawyer to stop them.She explained that her late husband had been a breeder of champion thoroughbreds. The couple was a familiar sight at the racetracks in Chantilly and Paris: Daniel Wildenstein, gray-suited with a cane in the stands, and Sylvia Roth Wildenstein, a former model with a cigarette dangling from her lips. They first met in 1964, while she was walking couture shows in Paris and he was languishing in a marriage of convenience to a woman from another wealthy Jewish family of art collectors. Daniel, 16 years Sylvia’s senior, already had two grown sons when they met, and he didn’t want more children. So over the next 40 years they spent together, Sylvia cared for the horses as if they were the children she never had. When Daniel died of cancer in 2001, he left her a small stable.Then, one morning about a year later, Sylvia’s phone rang. It was her horse trainer calling to say that he had spotted something odd in the local racing paper, Paris Turf: The results of Sylvia’s stable were no longer listed under her name. The French journalist Magali Serre’s 2013 book “Les Wildenstein” recounts the scene in great detail: Sylvia ran to fetch her copy and flipped to the page. Sure enough, the stable of “Madame Wildenstein” had been replaced by “Dayton Limited,” an Irish company owned by her stepsons.This story was recorded by Audm. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.

Speaker Kevin McCarthy has ordered an impeachment inquiry into President Biden, putting into motion the third formal attempt by Congress to remove a president in the past four years.Luke Broadwater,  a congressional reporter for The Times, explains the unique realities behind this one.Guest: Luke Broadwater, a congressional reporter for The New York Times.Background reading: Mr. McCarthy, who formerly argued that the House must vote before opening an impeachment inquiry, changed his tune this week.What we know about the impeachment case against Mr. Biden.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

In a rare move, the leader of North Korea, Kim Jong-un, traveled outside his country this week to meet with the Russian president, Vladimir V. Putin. Julian Barnes, a national security reporter for The New York Times, explains what Russia wants from North Korea and how far Mr. Putin might go to get it.Guest: Julian E. Barnes, a national security reporter for The New York Times.Background reading: Kim Jong-un has ammunition stocks that Russia covets as it continues its war in Ukraine, and North Korea may get advanced technology and badly needed food aid in return.Heading to Russia to meet with President Vladimir V. Putin, the North Korean leader chose to travel by rail, on a train with some unusual features.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

On Tuesday afternoon, the U.S. government recommended that almost every American begin taking a new annual vaccine for Covid, a milestone in the nation’s three-year battle against the virus.Apoorva Mandavilli, a science and global health reporter for The New York Times, explains why the era of booster shots is now over and how to navigate this latest uptick in infections.Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times.Background reading: The C.D.C. recommended all Americans aged 6 months and older should get at least one dose of new Covid vaccines.Covid continues to rise, but experts remain optimistic.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Later this week, as many as 150,000 U.S. autoworkers may walk out in a historic strike against the three Detroit automakers, General Motors, Ford and Stellantis. The United Auto Workers union and the Big Three are still far apart in talks, and have only two days left to negotiate a new labor contract before the deadline.Neal Boudette, who covers the auto industry for The New York Times, walks us through a tangled, decades-long dynamic and explains why a walkout looks increasingly likely.Guest: Neal E. Boudette, an auto industry correspondent for The New York Times.Background reading: An auto strike is looming that threatens to shut down Detroit’s Big Three.The United Auto Workers has said it is prepared to strike at General Motors, Ford and Stellantis if a deal is not reached before current contracts end.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

For years, the government has been trying to rein in Big Tech, pursuing some of the largest and most powerful companies on the internet. This week, the government takes on Google in the first monopoly trial of the modern internet era.David McCabe, who covers technology policy for The Times, discusses the case against the internet giant and what it might mean for the future if the it loses.Guest: David McCabe, a technology policy correspondent for The New York Times.Background reading: The 10-week trial amps up efforts to rein in Big Tech by targeting the core search business that turned Google into a $1.7 trillion behemoth.A federal judge said that the Justice Department could not move forward with a number of claims in antitrust complaints, narrowing the scope of the trial.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

In early 2021, a Wikipedia editor peered into the future and saw what looked like a funnel cloud on the horizon: the rise of GPT-3, a precursor to the new chatbots from OpenAI. When this editor — a prolific Wikipedian who goes by the handle Barkeep49 on the site — gave the new technology a try, he could see that it was untrustworthy. The bot would readily mix fictional elements (a false name, a false academic citation) into otherwise factual and coherent answers. But he had no doubts about its potential. “I think A.I.’s day of writing a high-quality encyclopedia is coming sooner rather than later,” he wrote in “Death of Wikipedia,” an essay that he posted under his handle on Wikipedia itself. He speculated that a computerized model could, in time, displace his beloved website and its human editors, just as Wikipedia had supplanted the Encyclopaedia Britannica, which in 2012 announced it was discontinuing its print publication.Recently, when I asked this editor if he still worried about his encyclopedia’s fate, he told me that the newer versions made him more convinced that ChatGPT was a threat. “It wouldn’t surprise me if things are fine for the next three years,” he said of Wikipedia, “and then, all of a sudden, in Year 4 or 5, things drop off a cliff.”This story was recorded by Audm. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.

This episode contains descriptions of severe injuries. Last week, a devastating fire swept through a derelict building in Johannesburg that housed desperate families who had no place else to go. The authorities had been repeatedly warned that it was a potential firetrap. Nothing was done, and at least 76 people died.Lynsey Chutel, who covers southern Africa for The Times, explains how Johannesburg, once a symbol of the hope of post-apartheid South Africa, became an emblem of just how bad the country’s breakdown has become.Guest: Lynsey Chutel, a southern Africa correspondent for The New York Times.Background reading: An extensive paper trail revealed that the authorities in Johannesburg were warned repeatedly about the dangers in the building that burned down.Johannesburg, with a severe shortage of affordable housing, has hundreds of illegally occupied derelict buildings that officials and housing advocates say have become firetraps.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.Rebecca Robbins, who covers the pharmaceutical industry for The Times, discusses one man’s case and how patents can create perverse incentives to delay new and better drugs.Guest: Rebecca Robbins, a business reporter covering the pharmaceutical industry for The New York Times.Background reading: Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents showed.In August, an expert panel recommended the new daily pill Descovy for H.I.V. prevention.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

In New York, the arrival of more than 100,000 migrants seeking asylum over the past year has become a crisis for the city’s shelter system, schools and budget.As another critical election season begins to take shape, Nicholas Fandos, who covers New York State politics for The Times, explains why the situation has also become a political crisis for the state’s Democratic leaders.Guest: Nicholas Fandos, a reporter covering New York State politics for The New York Times Metro desk.Background reading: New York’s migrant crisis is growing. So are Democrats’ anxieties.A scathing letter revealed tension among New York Democrats over the city’s migrant crisis.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

A Times investigation found that U.S. passenger planes come dangerously close to crashing into each other far more frequently than the public knows.Sydney Ember, an economics reporter for The Times, explains why an aviation system known for its safety is producing such a steady stream of close calls.Guest: Sydney Ember, an economics correspondent for The New York Times.Background reading: Airline close calls happen far more often than previously known.What you need to know about turbulence.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

A Times investigation revealed that in much of the United States, communities and farms are pumping out groundwater at alarming rates. Aquifers are shrinking nationwide, threatening supplies of drinking water and the country’s status as a food superpower.Christopher Flavelle, who covers climate adaptation for The Times, went to Arizona, the state at the forefront of the crisis, and looked at one especially controversial idea to address it: desalination.Guest: Christopher Flavelle covers climate adaptation for The New York Times.Background reading: America is using up its groundwater like there’s no tomorrow.Five takeaways from the investigation into the groundwater crisis.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

A year ago, Congress overhauled the way drugs for older Americans get paid for, by giving Medicare the power to bargain with drug makers over prices in the biggest change to health care for more than a decade. This week, the Biden administration began its implementation.Sheryl Gay Stolberg, who covers health policy for The Times, discusses the decades long battle for bargaining power and Rebecca Robbins, who covers the pharmaceutical industry for The Times, explains its potential to reshape the business of drugs in America.Guest: Sheryl Gay Stolberg, a Washington correspondent covering health policy for The New York Times.Rebecca Robbins, a business reporter for The New York Times covering the pharmaceutical industry.Background reading: The Biden administration announced a long-awaited list of the first 10 medicines that will be subject to price negotiations with Medicare.Drugmakers are “throwing the kitchen sink” to halt Medicare price negotiations.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.